全文获取类型
收费全文 | 2150969篇 |
免费 | 151250篇 |
国内免费 | 4230篇 |
专业分类
耳鼻咽喉 | 32279篇 |
儿科学 | 63896篇 |
妇产科学 | 59443篇 |
基础医学 | 304809篇 |
口腔科学 | 65689篇 |
临床医学 | 185228篇 |
内科学 | 414818篇 |
皮肤病学 | 48318篇 |
神经病学 | 171963篇 |
特种医学 | 86499篇 |
外国民族医学 | 521篇 |
外科学 | 337894篇 |
综合类 | 46080篇 |
现状与发展 | 7篇 |
一般理论 | 670篇 |
预防医学 | 148031篇 |
眼科学 | 52282篇 |
药学 | 163359篇 |
6篇 | |
中国医学 | 4824篇 |
肿瘤学 | 119833篇 |
出版年
2018年 | 21041篇 |
2017年 | 16785篇 |
2016年 | 19246篇 |
2015年 | 21643篇 |
2014年 | 29028篇 |
2013年 | 43481篇 |
2012年 | 58664篇 |
2011年 | 61146篇 |
2010年 | 36246篇 |
2009年 | 34434篇 |
2008年 | 59081篇 |
2007年 | 63521篇 |
2006年 | 64321篇 |
2005年 | 62778篇 |
2004年 | 60795篇 |
2003年 | 58760篇 |
2002年 | 57773篇 |
2001年 | 103889篇 |
2000年 | 106771篇 |
1999年 | 90246篇 |
1998年 | 23665篇 |
1997年 | 21272篇 |
1996年 | 20625篇 |
1995年 | 19401篇 |
1994年 | 18027篇 |
1992年 | 68889篇 |
1991年 | 66557篇 |
1990年 | 65251篇 |
1989年 | 63399篇 |
1988年 | 58671篇 |
1987年 | 57609篇 |
1986年 | 54585篇 |
1985年 | 52236篇 |
1984年 | 38569篇 |
1983年 | 32916篇 |
1982年 | 18980篇 |
1981年 | 17177篇 |
1979年 | 36687篇 |
1978年 | 25848篇 |
1977年 | 22462篇 |
1976年 | 20096篇 |
1975年 | 22716篇 |
1974年 | 27050篇 |
1973年 | 26112篇 |
1972年 | 24878篇 |
1971年 | 23347篇 |
1970年 | 22208篇 |
1969年 | 21109篇 |
1968年 | 19714篇 |
1967年 | 17703篇 |
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
91.
92.
Rafiye Ciftciler Haluk Demiroglu Yahya Buyukasık Elifcan Aladag Salih Aksu Ibrahim C. Haznedaroglu Nilgun Sayınalp Osman Ozcebe Umit Yavuz Malkan Hakan Goker 《Clinical Lymphoma, Myeloma & Leukemia》2019,19(3):177-182
Background
Refractory acute myeloid leukemia (AML) includes AML includes failure of disease to respond to standard induction chemotherapy, relapse within 6 months after first CR, and 2 or more relapses. The outcome of these patients is usually very poor; only a small proportion can be rescued by allogenic hematopoietic stem-cell transplantation (allo-HSCT). The aim of this study was to evaluate the efficacy and feasibility of allo-HSCT in patients with refractory AML.Patients and Methods
We retrospectively analyzed the clinical outcome of 91 patients who were diagnosed with treatment-refractory AML at Hacettepe University Hospital between January 2002 and June 2018. Patients' disease status included refractory AML, defined as failure to respond to standard induction chemotherapy and relapse within 6 months after first complete remission.Results
The median follow-up was 12 months (range, 0.5-184 months) for the entire group. Kaplan-Meier estimates of the 3-year overall survival for patients who underwent allo-HSCT and patients who received only salvage chemotherapy were 67% and 12%, respectively. Additionally, the Kaplan-Meier estimates of 5-year overall survival for patients who underwent allo-HSCT and patients who received only salvage chemotherapy were 44% and 4%, respectively (P < .001). Complete remission was obtained in 25 patients (83.3%) who underwent allo-HSCT; however, the disease of only 3 patients (3.8%) exhibited complete response after salvage chemotherapy.Conclusion
Allo-HSCT is still the best-known treatment option with curative potential in patients with treatment-refractory AML. Therefore, all efforts should be made in an attempt to find a suitable matched donor in order to perform allo-HSCT. 相似文献93.
A case of bullous pemphigoid associated with psoriasis vulgaris showing Hailey–Hailey disease‐like histopathological changes in regenerated epidermis without genomic mutation in ATP2C1 or ATP2A2 gene
下载免费PDF全文
![点击此处可从《Journal of the European Academy of Dermatology and Venereology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
94.
F. Fruzzetti G. Palla A. Sbrana T. Simoncini M. R. Sessa 《Gynecological endocrinology》2020,36(10):938-940
AbstractObjective: To understand the origin of extremely high gonadotropin levels in a perimenopausal woman.Methods: A 52-year-old woman with a 2?months of amenorrhea followed spontaneous menstrual cycles recovery was referred to our outpatient clinic with elevated follicle-stimulating hormone (FSH, 483 mUI/ml), luteinizing hormone (LH, 475 mUI/ml) and prolactin (PRL, 173?ng/ml). She was known to take levosulpiride. The gonadotropin levels did not fit with the clinical features.Results: A gonadotroph tumor was ruled out. Further analysis confirmed constantly high FSH, LH and PRL levels. The measurements were repeated using different analytical platforms with different results. After serial dilutions, nonlinearity was present suggesting an immunoassay interference. After post-polyethylene glycol recovery, hormone levels appeared in the normal range. Anti-goat antibodies were recognized in the serum of the patient.Conclusions: This case report shows a case of falsely abnormal high gonadotropin and PRL levels in a woman during menopause transition. In the clinical practice the evaluation of gonadotropin profile is not recommended at this age, but the abnormal levels stimulated further evaluation. An interference in the assay due to anti-goat antibodies resulted in abnormally high level of FSH and LH. A strict collaboration between clinicians and the laboratory is needed, when laboratory findings do not correspond to clinical findings. 相似文献
95.
AbstractWe have investigated communication preferences of mammography results in 90 patients through a structured interview approach. About 81% of patients expressed that they wanted to get the results, and 18% expressed that getting the results does not help if they are incomprehensible. In patients who want to get the results, 80% preferred face-to-face interaction with physicians, whereas the others preferred other modes of communication to prevent loss of time. Majority of patients infavor of face-to-face interaction (57%) preferred both the referring physician and the radiologist. Comprehensibility and fast delivery of reports, plus direct communication with radiologists are the requirements in mammography patients while implementing patient-centered radiology. 相似文献
96.
T. Wu L. G. Trahair M. J. Bound C. F. Deacon M. Horowitz C. K. Rayner K. L. Jones 《Diabetic medicine》2015,32(5):595-600
97.
98.
99.
100.
Harit Kapoor Kush Raj Lohani Tommy H. Lee Devendra K. Agrawal Sumeet K. Mittal 《CTS Clinical and Translational Science》2015,8(6):841-847
Esophageal adenocarcinoma is the fastest rising cancer in the United States. It develops from long‐standing gastroesophageal reflux disease which affects >20% of the general population. It carries a very poor prognosis with 5‐year survival <20%. The disease is known to sequentially progress from reflux esophagitis to a metaplastic precursor, Barrett''s esophagus and then onto dysplasia and esophageal adenocarcinoma. However, only few patients with reflux develop Barrett''s esophagus and only a minority of these turn malignant. The reason for this heterogeneity in clinical progression is unknown. To improve patient management, molecular changes which facilitate disease progression must be identified. Animal models can provide a comprehensive functional and anatomic platform for such a study. Rats and mice have been the most widely studied but disease homology with humans has been questioned. No animal model naturally simulates the inflammation to adenocarcinoma progression as in humans, with all models requiring surgical bypass or destruction of existing antireflux mechanisms. Valuable properties of individual models could be utilized to holistically evaluate disease progression. In this review paper, we critically examined the current animal models of Barrett''s esophagus, their differences and homologies with human disease and how they have shaped our current understanding of Barrett''s carcinogenesis. 相似文献